Works matching IS 1007385X AND DT 2021 AND VI 28 AND IP 3
1
- Chinese Journal of Cancer Biotherapy, 2021, v. 28, n. 3, p. 306, doi. 10.3872/j.issn.1007-385x.2021.03.014
- Article
2
- Chinese Journal of Cancer Biotherapy, 2021, v. 28, n. 3, p. 311, doi. 10.3872/j.issn.1007-385x.2021.03.015
- Article
3
- Chinese Journal of Cancer Biotherapy, 2021, v. 28, n. 3, p. 299, doi. 10.3872/j.issn.1007-385x.2021.03.013
- Article
4
- Chinese Journal of Cancer Biotherapy, 2021, v. 28, n. 3, p. 294, doi. 10.3872/j.issn.1007-385x.2021.03.012
- Article
5
- Chinese Journal of Cancer Biotherapy, 2021, v. 28, n. 3, p. 288, doi. 10.3872/j.issn.1007-385x.2021.03.011
- Article
6
- Chinese Journal of Cancer Biotherapy, 2021, v. 28, n. 3, p. 283, doi. 10.3872/j.issn.1007-385x.2021.03.010
- Article
7
- Chinese Journal of Cancer Biotherapy, 2021, v. 28, n. 3, p. 275, doi. 10.3872/j.issn.1007-385x.2021.03.009
- Article
8
- Chinese Journal of Cancer Biotherapy, 2021, v. 28, n. 3, p. 269, doi. 10.3872/j.issn.1007-385x.2021.03.008
- Article
9
- Chinese Journal of Cancer Biotherapy, 2021, v. 28, n. 3, p. 261, doi. 10.3872/j.issn.1007-385x.2021.03.007
- Article
10
- Chinese Journal of Cancer Biotherapy, 2021, v. 28, n. 3, p. 254, doi. 10.3872/j.issn.1007-385x.2021.03.006
- 王一同;
- 卢鸿健;
- 孔艺璇;
- 苏静慧;
- 刘雨谭;
- 张荣花;
- 侯晓丽;
- 章广玲
- Article
11
- Chinese Journal of Cancer Biotherapy, 2021, v. 28, n. 3, p. 247, doi. 10.3872/j.issn.1007-385x.2021.03.005
- Article
12
- Chinese Journal of Cancer Biotherapy, 2021, v. 28, n. 3, p. 239, doi. 10.3872/j.issn.1007-385x.2021.03.004
- 张蕙雯;
- 杨婷;
- 禹卓玥;
- 孙立新;
- 刘军;
- 遇珑;
- 孙力超;
- 冉宇靓
- Article
13
- Chinese Journal of Cancer Biotherapy, 2021, v. 28, n. 3, p. 232, doi. 10.3872/j.issn.1007-385x.2021.03.003
- Article
14
- Chinese Journal of Cancer Biotherapy, 2021, v. 28, n. 3, p. 225, doi. 10.3872/j.issn.1007-385x.2021.03.002
- Article
15
- Chinese Journal of Cancer Biotherapy, 2021, v. 28, n. 3, p. 215, doi. 10.3872/j.issn.1007-385x.2021.03.001
- Article